5 participants
Comparing the Effectiveness of IV Bezlotoxumab Versus Placebo in Decreasing Morbidity and Mortality in Patients With Fulminant C. Diff Requiring Surgery.
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-06-18
- Start Date:
- 2019-08-19
- Completion:
- 2022-05-23
Conditions
- Clostridia Difficile Colitis
- Clostridium; Sepsis
Interventions
- BIOLOGICAL
- OTHER